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Tubular heart valves
To the Editor:
Cox and associates1 recently presented in vitro
testing results on the 3F Aortic Bioprosthesis.
Unfortunately, Cox and colleagues chose
not to give authorship to any of the engi-
neers who performed this work, nor even
give them the courtesy of an acknowledge-
ment. Due to the lack of input from these
engineers, of whom I am one, the article
contains several technical and interpretive
errors that should be corrected. They are as
follows:
● The text gives the impression that a
laser micrometer was used to mea-
sure aortic chamber compliance dur-
ing flow testing. Those measurements
were actually made on valveless cham-
bers in a separate test system before
flow testing.
● The paper states, “Five milliliters of
corn starch was . . . injected into the
flow loop to act as an acoustic scat-
tering agent.” This is nonsensical
since laser-based flow visualization
does not employ acoustic scatter in
any way. The statement refers to a
technique used during in vitro Dopp-
ler studies and is presumably a “copy
and paste” error.
● Wear testing of the valve was not
conducted at 700 to 900 Hz as im-
plied. The test rate was 700 to 900
rpm, which is about 12 to 15 Hz.
● Wear testing was not conducted on
valve sizes 19-, 21-, 23-, 25-, and
27-mm valves, 2 of each size, as
stated. Testing was conducted on 19-,
25-, and 29-mm valves, 10 of each
size.
● The authors state, “This nonturbulent
flow was characteristic of . . . all valve
sizes . . ..” Since flow visualization
testing was only conducted on
19-mm valves, this is conjecture be-
ing stated as fact.
● The authors state, “The distribution of
stress on the leaflets of the 3F Aortic
Bioprosthesis shows the greatest de-
gree of stress to be in the belly of the
valve leaflets, with less stress at the
commissural posts (Figure 6).” This
statement is actually in direct contra-
diction to Figure 6. The figure clearly
shows the largest stresses to be along
the leaflet edge and at the commis-
sural attachment point.
These corrections are not intended to be
petty or esoteric. As the clinical use of the
3F aortic valve continues to grow, it is
important to have accurate literature re-
ports of how the valve has been tested, as
well as sound technical analyses of its per-
formance features. Rather than relying on
ill-conceived theories of “tubular” geome-
try or “form follows function,” the valve’s
excellent performance can be attributed to
more straightforward design features (ie,
the leaflet design, the small, unobstructive
sewing ring, the lack of rigid supports
structures, and the mechanical durability of
pericardium). An intellectually and scien-
tifically rigorous paper with a description
of these features and how they translate to
the observed performance would have been
much more useful.
Brian Biancucci
Ann Arbor, Mich
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Effectively treating ischemic mitral
regurgitation with chordal cuttling in
combination with ring annuloplasty
and a left ventricular reshaping
approach
To the Editor:
I read with great interest the case reported
by Yamamoto and colleagues1 in the Au-
gust 2005 issue of the Journal. In the arti-
cle the authors presented a patient in whom
they repaired chronic ischemic mitral re-
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